Evidence map›Paper›PMID 23796751›Full record

ReviewBiochemical pharmacology2013

Nicotinic modulation of intrinsic brain networks in schizophrenia.

Jason Smucny, Jason Tregellas

Open access · greenAbstract readReview
In one paragraph

Review in Biochemical pharmacology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Cognitive Control, the Anterior Cingulate, and Nicotinic Receptors: A Case of Heterozygote Advantage.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2018
    Article
  7. Review
  8. Review
  9. Probing Intrinsic Resting-State Networks in the Infant Rat Brain.Frontiers in behavioral neuroscience · 2016
    Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Jason SmucnyNeuroscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Department of Psychiatry, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA; Research Service, Denver VA Medical Center, Denver, CO 80220, USA. Electronic address: Jason.smucny@ucdenver.edu.
Jason Tregellas
Denver VA Medical Center · USUniversity of Colorado Anschutz Medical Campus · US

Funding

Functional Imaging of the Nicotinic Basis for Attention Deficits in SchizophreniaF31MH102879 · NIMH · UNIVERSITY OF COLORADO DENVER · PI SMUCNY, JASON · 2014 to 2016
$76k
NIMH NIH HHS F31 MH102879
6 · The paper itself

Abstract

The nicotinic receptor is a promising drug target currently being investigated for the treatment of cognitive symptoms in schizophrenia. A key step in this process is the development of noninvasive functional neuroimaging biomarkers that can be used to determine if nicotinic agents are eliciting their targeted biological effect, ideally through modulation of a fundamental aspect of neuronal function. To that end, neuroimaging researchers are beginning to understand how nicotinic modulation affects "intrinsic" brain networks to elicit potentially therapeutic effects. An intrinsic network is a functionally and (often) structurally connected network of brain areas whose activity reflects a fundamental neurobiological organizational principle of the brain. This review summarizes findings of the effects of nicotinic drugs on three topics related to intrinsic brain network activity: (1) the default mode network, a group of brain areas for which activity is maximal at rest and reduced during cognitive tasks, (2) the salience network, which integrates incoming sensory data with prior internal representations to guide future actions and change predictive values, and (3) multi-scale complex network dynamics, which describe these brain's ability to efficiency integrate information while preserving local functional specialization. These early findings can be used to inform future neuroimaging studies that examine the network effects of nicotinic agents.

Indexed as

Antipsychotic AgentsBrainCholinergic AgentsHumansNerve NetReceptors, NicotinicSchizophreniaAntipsychotic AgentsCholinergic AgentsReceptors, NicotinicDefault networkNicotinicSalience networkSchizophreniaSmall-world network

Identifiers

PMID23796751
PMCPMC4103690
OpenAlexW2079238163

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.